A client with atrial fibrillation and a mechanical mitral valve asks which oral anticoagulant is expected for long-term stroke and valve-thrombosis prevention. Which response is best?
1Aspirin alone because atrial fibrillation is intermittent
2Warfarin with valve-specific INR monitoring✓ Correct answer
3Apixaban without laboratory or valve review
4Clopidogrel alone because it acts on platelets
Explanation
Vitamin K antagonist therapy is recommended for mechanical valves; direct oral anticoagulants are not used as substitutes in this setting.
Quick answer Expect warfarin with valve-specific INR monitoring.
Why this is correct ACC/AHA guidance excludes mechanical valves from the usual preference for DOACs in atrial fibrillation. The valve type and thromboembolic risk determine the VKA target and monitoring plan.
Easy analogy or mental picture A mechanical valve requires the anticoagulant lane with established valve evidence, not a convenient shortcut.
Memory hook Mechanical valve means VKA, not DOAC substitution.
NCLEX decision rule Identify the valve before applying the general atrial-fibrillation anticoagulant rule.
Why the other choices are wrong Aspirin or clopidogrel alone does not replace anticoagulation, and apixaban is not the expected mechanical-valve therapy.
References
1ACC/AHA 2023 Atrial Fibrillation GuidelineDOAC preference exceptions for mechanical valves and moderate-to-severe mitral stenosis
2ACC/AHA 2020 Valvular Heart Disease GuidelineVKA therapy for mechanical valves, pregnancy counseling, and monitored anticoagulation planning
Valve anticoagulant verificationConfirm valve position and type, rhythm, prior thromboembolism, INR goal, interacting drugs, adherence, bleeding, and monitoring access.